Grundinformationen
- Standard-SMILES
COc1cc(S(C)=O)ccc1-c1nc2ncccc2[nH]1- InChIKey
XMFCOYRWYYXZMY-UHFFFAOYSA-N- Summenformel
- C14H13N3O2S
- Durchschnittliche Molmasse
- 287,34 g/mol
- Monoisotopische Masse
- 287,07284766
Überblick
Sulmazole is an imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent. It has a role as a cardiotonic drug, an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor and an adenosine A1 receptor antagonist. It is a sulfoxide and an imidazopyridine.
Namen und Bezeichner
- Bevorzugter Name
- Sulmazole
- IUPAC
- 2-(2-methoxy-4-methylsulfinylphenyl)-1H-imidazo[4,5-b]pyridine
- Lokaler Name
- Sulmazol
- Englischer Name
- 2-[2-METHOXY-4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZO[4,5-B]PYRIDINE
- Summenformel
- C14H13N3O2S
- Molmasse
- 287.34
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
73384-60-8- PubChem CID
- 5353
- DTXSID
DTXSID1040617- ChEMBL
CHEMBL286020- ChEBI
CHEBI:34988- UNII
- HK56EH9K44
- EC Number
- 277-406-1
- Nikkaji
- J11.238K
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,2
- Polarare Oberfläche (TPSA)
- 87,1 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 368
Experimentelle und physikochemische Eigenschaften
Collision Cross Section
166.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
178.7 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physikochemische Eigenschaften
- Schmelzpunkt
- 203 · 203-205°
- Siedepunkt
- 527.3 · 527.3±60.0 °C(Predicted)
- Dichte
- 1.43 · 1.43±0.1 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C
- pka
- 6 · 6+-.0.20(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Sicherheitsdaten
- wgk
- 3
- RTECS-Nr.
- NJ5749500
- risk_code
- 22-36/37/38
- Toxizität
- LD50 in albino mice (mg/kg): 560 orally; 163 i.v. (Diederen, Kadatz)
- hazard_code
- Xn
- safety_code
- 26-36
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.
Anbieter13 Anbieter
Ergänzende Hinweise
DefinitionChEBI: An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardi tonic agent.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…